EE251 A Budget Impact Analysis of the Introduction of Generics Ambrisentan and Tadalafil for the Treatment of Pulmonary Arterial Hypertension in Greece

N Nomikos,I Kyriopoulos,K Athanasakis

doi:10.1016/j.jval.2022.09.499

EE251 A Budget Impact Analysis of the Introduction of Generics Ambrisentan and Tadalafil for the Treatment of Pulmonary Arterial Hypertension in Greece

N Nomikos, I Kyriopoulos + Show 1 more

Open Access

https://doi.org/10.1016/j.jval.2022.09.499

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: Dec 1, 2022
License type: publisher-specific-oa

Affiliation: London School of Economics and Political Science, University of West Attica

#Hypertension In Greece #Treatment Of Pulmonary Arterial Hypertension + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

The purpose of this study was to estimate the potential budget impact of the introduction and uptake of generics of Ambrisentan and Tadalafil for the treatment of Pulmonary Arterial Hypertension (PAH) in Greece.

Full Text